Travis B. Dick, PharmD, MBA, BCPS, CPEL, FASHP (travis_dick@urmc.rochester.edu), is the senior director of clinical pharmacy practice, research, and education and PGY1 pharmacy residency program director at the University of Rochester where he is responsible for setting system strategy, establishing medication use policy, and ensuring regulatory accreditation. He received his PharmD from the University of North Carolina-Chapel Hill and completed both PGY1 pharmacy and PGY2 solid organ transplant residencies at Duke University. He also holds an MBA from the University of Utah and is recognized as a Certified Pharmacy Executive Leader (CPEL).
Dick’s leadership in ASHP includes serving as chair of the Educational Steering Committee and advisory group on Frontline Leaders for the Section of Pharmacy Practice Leaders. He is a current member of the Council on Education and Workforce Development and International Accreditation Commission, has been a guest surveyor for pharmacy residency programs, and served as a delegate to the ASHP House of Delegates. As a result of his commitment to ASHP, he was recognized as a Fellow in 2023.
Dick has been active at the state level. He is a past president of the New York State Council of Health-system Pharmacists and previously served on the Utah Society of Health-System Pharmacists Board of Directors.
Meet Travis B. Dick
The pharmacy profession is at an inflection point. Medication use, misuse, pharmacy deserts, targeted therapies, and drug costs are all on the rise. Increasing threats to the workforce and profession seem ubiquitous: workplace violence, cyber-attacks, drug shortages, eroding margins, industry disruptors, and staffing shortages are just a few. There are also exciting advancements including artificial intelligence, cellular and gene therapies, alternative sites of care, digital innovations, and advances in legislative frameworks such as standard of care.
Now is the time to future-proof the profession as we are best positioned to improve patient care outcomes, innovate healthcare delivery models, and drive positive value for our health-systems. ASHP and the Section are primed to confront uncertainties and capitalize on these opportunities. Harnessing and integrating technology, developing value-based clinical metrics and pharmacy-sensitive indicators, positively influencing population health, and creating care delivery models for a thriving workforce are essential. We can further optimize financial performance by advocating for reform around 340b, pharmacy benefit manager pressures, and creating infrastructure for ultra-high-cost drugs.
My experience practicing across the country has afforded me opportunities to see different practices and styles. Building efficient systems, optimizing safe practices, developing a thriving workforce, and increasing visibility are passions of mine in health-system pharmacy leadership. If elected, I look forward to offering unique, actionable perspectives on how we can sustainably shape clinical, operational, financial, and regulatory models. I am honored to be nominated and excited about the opportunity to serve the Section and help ASHP advance pharmacy practice and our profession.